Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation

Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation

Abstract Background The five-tiered Cambridge Prognostic Group (CPG) classification is a better predictor of prostate cancer-specific mortality than the traditional three-tiered classification (low, intermediate, and high risk). We investigated radical treatment rates according to CPG in men diagnos...

Full description

Bibliographic Details
Main Authors: M. G. Parry, T. E. Cowling, A. Sujenthiran, J. Nossiter, B. Berry, P. Cathcart, A. Aggarwal, H. Payne, J. van der Meulen, N. W. Clarke, V. J. Gnanapragasam
Format: Article
Language:English
Published: BMC 2020-05-01
Series:BMC Medicine
Subjects:
Prostate cancer
Non-metastatic disease
Risk stratification
Cambridge Prognostic Groups
CPG
Treatment selection
Online Access:http://link.springer.com/article/10.1186/s12916-020-01588-9

Internet

http://link.springer.com/article/10.1186/s12916-020-01588-9

Similar Items